Jay Pomerantz focuses his practice on representing technology companies and their directors and officers in securities class actions; derivative litigation; internal investigations; audit and board committee representations; SEC and regulatory matters; and corporate governance issues.
Jay has extensive experience litigating complex matters before federal and state courts, and representing companies, board committees and directors and officers in internal investigations and regulatory matters. He has represented audit and board committees of numerous companies with substantial China operations, as well as the officers and employees of these companies, in internal and regulatory investigations related to the Foreign Corrupt Practices Act (FCPA), revenue recognition and related accounting issues. Jay has also represented numerous biotech companies and their directors and officers in connection with securities class actions, derivative suits, and SEC regulatory proceedings. In 2013, Fenwick’s Securities Litigation team was named “Securities Litigation Department of the Year” by The Recorder over 20 other California firms.
Recent matters include internal investigations related to stock option pricing issues; defending companies and their directors and officers in securities class actions and derivative suits; conducting internal investigations for audit, compensation and other board committees related to accounting, FCPA, corporate governance and Sarbanes-Oxley issues; representing companies and individuals in SEC regulatory matters and defending against insider trading claims; and advising on corporate governance and D&O liability insurance issues. He has represented clients in numerous technology sectors, including biotech, semiconductor, software, digital media, Internet and Internet security, biometrics and telecommunications.